Background: Circular RNAs (circRNAs) function as essential regulators in diverse human cancers, including hepatocellular carcinoma (HCC). However, the function of circ_0000517 in HCC was unknown. We aimed to explore the roles and mechanisms of circ_0000517 in HCC.

Materials And Methods: The levels of circ_0000517, RPPH1 mRNA and microRNA-1296-5p (miR-1296-5p) were measured using quantitative real-time polymerase chain reaction (qRT-PCR). The characteristics of circ_0000517 were explored by RNase R digestion and actinomycin D assays. Cell proliferation was evaluated by Cell Counting Kit-8 (CCK-8) and colony formation assays. Cell cycle process and cell apoptosis were analyzed by flow cytometry analysis. The function of circ_0000517 in vivo was explored by a murine xenograft model. The association between miR-1296-5p and circ_0000517 or thioredoxin domain containing 5 (TXNDC5) was determined by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. The protein level of TXNDC5 was detected by Western blot assay.

Results: Circ_0000517 was upregulated in HCC tissues and cells. Silencing of circ_0000517 suppressed HCC cell viability and colony formation and promoted cell cycle arrest and apoptosis in vitro and hampered tumor growth in vivo. MiR-1296-5p was a target of circ_0000517 and the effects of circ_0000517 silencing on HCC cell viability, cell cycle, colony formation and apoptosis were abolished by miR-1296-5p inhibition. TXNDC5 functioned as a target gene of miR-1296-5p, and the inhibitory effect of miR-1296-5p on HCC cell progression was rescued by TXNDC5 overexpression. Moreover, circ_0000517 promoted TXNDC5 expression via targeting miR-1296-5p.

Conclusion: Circ_0000517 accelerated HCC progression by upregulating TXNDC5 through sponging miR-1296-5p.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234960PMC
http://dx.doi.org/10.2147/CMAR.S244024DOI Listing

Publication Analysis

Top Keywords

circ_0000517
13
colony formation
12
cell cycle
12
hcc cell
12
cell
9
hepatocellular carcinoma
8
progression upregulating
8
upregulating txndc5
8
txndc5 sponging
8
mir-1296-5p
8

Similar Publications

Article Synopsis
  • Multiple sclerosis (MS) is an autoimmune disease linked to both genetic and environmental factors, involving the immune system and myelin changes associated with RNA, particularly circular RNAs (circRNAs).
  • A study analyzed circRNA expressions in peripheral blood mononuclear cells (PBMCs) from five newly diagnosed MS patients and five healthy controls, using a microarray to identify significant differences.
  • The research found 64 differentially expressed circRNAs, with 53 downregulated in MS patients, validated in a larger cohort, suggesting a specific circRNA as a potential biomarker for MS severity and progression.
View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is extremely fatal and potential biomarkers for precision medicine of patients with PDAC are yet to be elucidated. Moreover, the clinical values of circular RNAs (circRNAs) in PDAC management are yet to be investigated. The aim of the present study was to perform a secondary analysis of two PDAC public datasets (GSE69362 and GSE79634), to identify the candidate circRNAs, to validate the expression of these circRNAs, and to determine their association with the clinicopathological characteristics and survival of patients with PDAC.

View Article and Find Full Text PDF

Objective: There is growing evidence showing that circular RNAs (circRNAs) are crucial regulators in modulating the biological behavior of tumors. This work is aimed to probe the role of in non-small cell lung cancer (NSCLC) and to elucidate its mechanism of action.

Materials And Methods: In this experimental study, the differentially expressed circRNAs in NSCLC were screened using the GEO database (GSE158695).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!